PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETER MARKET ANALYSIS

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market, By Product Type (Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter, and Scoring Balloon Catheter), By Ballon Material (Polyolefin copolymer (POC), Polyethylene (PE) and Polyethylene terephthalate (PET)), By Application (Peripheral Artery Disease and Coronary Artery Disease), By End User (Hospitals, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Nov 2024
Code : CMI5194
Pages :180
Formats :
Excel and PDF
Industry : Medical Devices

Key Takeaways from Analyst

Technological advancements in PTCA balloon catheters will be a major driver. Companies are developing lower profile and more trackable balloon catheters which enable transcatheter therapies. The demand for PTCA procedures is growing in developing nations due to the rising prevalence of cardiac diseases. Increased healthcare spending in these nations presents new market opportunities.

Manufacturers should focus on developing economies in Asia Pacific and Latin America to tap higher growth potentials. Japan is another lucrative market due to increased adoption of minimally invasive cardiac procedures.

However, dominance of drug eluting stents over plain old balloon angioplasty restrains the percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market growth. Further, affordability issues in underdeveloped regions hamper the market growth. Developed markets in North America account for the bulk of current revenues. Asia Pacific excluding Japan follows in terms of market attractiveness due to huge patient population and improving healthcare infrastructure.